Advertisement
Screener

PTC Therapeutics, Inc. (PTCT) Analyst Insights

RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$65.42(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$65.42High(m)Average(m)Low(m)2025-11-062026-11-06
DateStockAnalystFirmPrice When RatedPrice TargetUpside / DownsideRatingPerformance
2026-08-13PTCT
PTC THERAPEUTICS, INC.
Eliana Merle, CFABarclays$72.64$122.00+67.95%Overweight
2026-02-20PTCT
PTC THERAPEUTICS, INC.
Eliana Merle, CFABarclays$68.93$120.00+74.09%Overweight
2026-01-27PTCT
PTC THERAPEUTICS, INC.
Eliana Merle, CFABarclays$75.25$119.00+58.14%Overweight
2025-11-05PTCT
PTC THERAPEUTICS, INC.
Eliana Merle, CFABarclays$67.72$68.00+0.41%Equal Weight
2025-07-29PTCT
PTC THERAPEUTICS, INC.
Eliana Merle, CFABarclays$44.34$46.00+3.74%Equal Weight
2025-05-07PTCT
PTC THERAPEUTICS, INC.
Eliana Merle, CFABarclays$36.19$42.00+16.05%Equal Weight
2024-12-02PTCT
PTC THERAPEUTICS, INC.
Eliana Merle, CFABarclays$52.07$56.00+7.55%Equal Weight
2024-11-13PTCT
PTC THERAPEUTICS, INC.
Eliana Merle, CFABarclays$44.03$45.00+2.20%Equal Weight
2024-11-08PTCT
PTC THERAPEUTICS, INC.
Eliana Merle, CFABarclays$42.96$43.00+0.09%Equal Weight
2024-08-08PTCT
PTC THERAPEUTICS, INC.
Eliana Merle, CFABarclays$32.45$31.00-4.47%Equal Weight
2023-10-26PTCT
PTC THERAPEUTICS, INC.
Eliana Merle, CFABarclays$23.95$25.00+4.38%Equal Weight

Similar stocks

Stock NameCountryMarket CapPE Ratio
Dianthus Therapeutics, Inc. /DE/ (DNTH)United States$5.082B-27.79
Erasca, Inc. (ERAS)United States$5.073B-19.96
Gossamer Bio, Inc. (GOSS)United States$5.355B-0.65
Cogent Biosciences, Inc. (COGT)United States$5.450B-17.61
Veradermics, Inc (MANE)United States$4.839B
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Edgewise Therapeutics, Inc. (EWTX)United States$4.470B-22.23
Viking Therapeutics, Inc. (VKTX)United States$4.287B-8.51